American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

Dec. 20, 2025 — American Express Company (NYSE: AXP) is ending the year near fresh highs as investors weigh two competing narratives: a resilient premium-spending backdrop that continues to support card volumes and fee growth, and a late-2025 policy and
Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Updated: December 20, 2025 — Philip Morris International Inc. (NYSE: PM) stock is ending the week in the spotlight as investors balance a resilient dividend story with a fast-moving U.S. “smoke-free” growth narrative built around ZYN nicotine pouches and the
Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Updated: December 20, 2025 Gilead Sciences, Inc. (NASDAQ: GILD) heads into the weekend with fresh policy headlines, a high-profile pricing agreement tied to the Trump administration’s TrumpRx initiative, and renewed attention on the company’s next-generation HIV portfolio. The combination has
Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Dec. 20, 2025 — Intuit Inc. (NASDAQ: INTU) enters the weekend with investors balancing a fresh fintech headline—Intuit’s newly announced USDC stablecoin partnership with Circle—against the familiar seasonal catalyst that often defines the stock’s narrative: TurboTax demand heading into the
Adobe Stock (ADBE) News on Dec. 20, 2025: Earnings, AI Firefly Expansion, Runway & ChatGPT Deals, Analyst Price Targets, and Lawsuit Risk

Adobe Stock (ADBE) News on Dec. 20, 2025: Earnings, AI Firefly Expansion, Runway & ChatGPT Deals, Analyst Price Targets, and Lawsuit Risk

Adobe Inc. (NASDAQ: ADBE) heads into the final full week before year-end with a familiar split-screen story for investors: record results and upbeat fiscal 2026 targets on one side, and growing debate over AI-era competition and legal risk on the
Chevron Stock (CVX) News Today, Dec. 20, 2025: Venezuela Blockade Risk, Guyana Growth, and 2026 Buyback Outlook

Chevron Stock (CVX) News Today, Dec. 20, 2025: Venezuela Blockade Risk, Guyana Growth, and 2026 Buyback Outlook

December 20, 2025 — Chevron Corporation (NYSE: CVX) is heading into year-end with investors balancing two powerful forces: geopolitical volatility (especially around Venezuela) and big, company-specific catalysts tied to Guyana, disciplined capital spending, and shareholder returns. Chevron stock last traded
IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

International Business Machines Corporation (NYSE: IBM) enters the final stretch of 2025 with its stock consolidating near the $300 level—an area that has become a focal point for both bulls betting on IBM’s “AI + hybrid cloud” strategy and skeptics
Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated (NASDAQ: INSM) is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close (the last U.S.
Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood Markets, Inc. (NASDAQ: HOOD) is closing out mid-December with investor attention locked on a single theme: the company’s rapid shift from a “commission-free broker” into a broader trading-and-betting marketplace, powered by prediction markets, expanding crypto capabilities, and new international
Go toTop